Through deterministic data linkage of health registries, mRNA vaccine effectiveness (VE) against COVID-19-related hospitalisations and deaths was measured in 1,880,351 older adults. VE against hospitalisations was 94% (95% confidence interval (CI): 88–97) and 82% (95% CI: 72–89) for those 65–79 and ≥ 80 years old, with no evidence of waning 98 days after dose two. VE against mortality was 96% (95% CI: 92–98) and 81% (95% CI: 74–87) in these two age groups.
All Keywords
【저자키워드】 SARS-CoV-2, Older adults, vaccine effectiveness, hospitalisation, COVID-19 related death, 【초록키워드】 Mortality, mRNA vaccine, Adults, Health, Effectiveness, death, age, Evidence, dose, Older, 95% confidence interval, was measured, groups, 【제목키워드】 mRNA vaccine, cohort study, Health, Effectiveness, death, Portugal, Older, National,
【저자키워드】 SARS-CoV-2, Older adults, vaccine effectiveness, hospitalisation, COVID-19 related death, 【초록키워드】 Mortality, mRNA vaccine, Adults, Health, Effectiveness, death, age, Evidence, dose, Older, 95% confidence interval, was measured, groups, 【제목키워드】 mRNA vaccine, cohort study, Health, Effectiveness, death, Portugal, Older, National,